Home › Preeclampsia › NCT07222852

Cardiovascular Protection After Preeclampsia With Enalapril

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Postpartum individuals
* ≥18 years old
* Hypertensive disorder of pregnancy
* Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program.

Exclusion Criteria:

* Maternal cardiac disease
* Individuals with pre-pregnancy hypertension or diabetes
* Allergy or contraindication to enalapril

About the study

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

What is being tested

• Enalapril (drug)
• Standard treatment (other)

Sponsor: Women and Infants Hospital of Rhode Island · Participants: 60 · Started: Jan 1, 2026

Contact the study team

• Alisse Hauspurg, MD · Phone: 401-274-1122

Official record on ClinicalTrials.gov — NCT07222852

Locations in the U.S.

Conditions

• Preeclampsia
• Toxemia
• High Blood Pressure
• High Blood Pressure in Pregnancy

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.